Fig. 5
From: Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ
Kaplan–Meier curves show the association between DCIS risk and local recurrence-free interval in patients treated with breast-conserving surgery based on Van Nuys Prognostic Index alone (a), and when legumain was incorporated with the Van Nuys Prognostic Index (b)
